Headache News and Research

Latest Headache News and Research

Astellas, Medivation submit European Marketing Authorization Application for XTANDI capsules

Astellas Pharma Inc. and Medivation Inc. today announced the submission of a variation to amend the European Marketing Authorization Application for XTANDI® (enzalutamide) capsules for the treatment of adult men with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy and in whom chemotherapy is not yet clinically indicated.

4 Apr 2014

ER physicians discount early signs of strokes among women, minorities, younger people

Analyzing federal health care data, a team of researchers led by a Johns Hopkins specialist concluded that doctors overlook or discount the early signs of potentially disabling strokes in tens of thousands of American each year, a large number of them visitors to emergency rooms complaining of dizziness or headaches.

4 Apr 2014

Doctors overlook early signs of strokes in people each year

4 Apr 2014

Researchers identify possible way to prevent headaches of climbers

By monitoring blood flow in the brains of six climbers scaling Mount Kilimanjaro in Tanzania, German medical researchers have identified a possible way to prevent the headaches that are a common feature of altitude sickness. This work appears in the latest issue of JNIRS—Journal of Near Infrared Spectroscopy.

4 Apr 2014

Gilead reports topline results from sofosbuvir Phase 3 trial in Japan for treatment of HCV infection

Gilead Sciences, Inc. today announced topline results from a Phase 3 clinical trial (Study GS-US-334-0118) in Japan evaluating the once-daily nucleotide analog polymerase inhibitor sofosbuvir in combination with ribavirin (RBV) for the treatment of genotype 2 chronic hepatitis C virus (HCV) infection.

3 Apr 2014

Frail elderly people are at increased risk of death from outbreaks of viral gastroenteritis

Frail elderly people living in residential care facilities are at increased risk of severe illness or death from outbreaks of viral gastroenteritis.

3 Apr 2014

FDA expands age indication of Adacel vaccine for immunization against tetanus, diphtheria, pertussis

Sanofi Pasteur, the vaccines division of Sanofi, announced today that the U.S. Food and Drug Administration (FDA) has expanded the approved age indication of Adacel® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed; Tdap) for active booster immunization for the prevention of tetanus, diphtheria, and pertussis as a single dose in persons 10 through 64 years of age.

2 Apr 2014

Looking forward: How to judge the rollout; challenges to come

Following the official end of the enrollment season, some outlets turn their attention to the upcoming issues surrounding the law.

2 Apr 2014

UT Southwestern launches telemedicine program to extend stroke care to patients in rural areas

UT Southwestern Medical Center has launched a state-of-the-art telemedicine program that will extend immediate access to UT Southwestern's nationally recognized stroke care during the crucial time period when treatment is needed for a patient of an ischemic stroke, or clot in one of the brain's blood vessels.

1 Apr 2014

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Amgen (NASDAQ: AMGN) today announced new detailed data from three Phase 3 studies that showed treatment with its novel investigational cholesterol-lowering medication, evolocumab (AMG 145), resulted in a statistically significant reduction of 55-66 percent in low-density lipoprotein cholesterol (LDL-C) compared to placebo in patients with high cholesterol.

31 Mar 2014

Biogen Idec's ALPROLIX receives FDA approval for hemophilia B treatment

Today Biogen Idec announced that the U.S. Food and Drug Administration has approved ALPROLIX [Coagulation Factor IX (Recombinant), Fc Fusion Protein], the first recombinant, DNA derived hemophilia B therapy with prolonged circulation in the body.

29 Mar 2014

States work to clarify enrollment rules, untangle technical problems as open enrollment period moves toward its close

News outlets also report that states are still conducting outreach efforts and offering the latest tallies of people who are signing up as well as information about subsidies.

29 Mar 2014

First Edition: March 28, 2014

The White House said on Thursday that more than six million people had signed up for medical insurance plans under President Obama's health care law, exceeding the administration's revised goal for enrollment by the Monday deadline.

28 Mar 2014

CDC identifies six new cases of people with Heartland virus

The Centers for Disease Control and Prevention in collaboration with health officials in Missouri and Tennessee have identified six new cases of people sick with Heartland virus: five in Missouri and one in Tennessee. The new cases, discovered in 2012 and 2013, are described today in CDC's Morbidity and Mortality Weekly Report.

28 Mar 2014

Study highlights importance of stress management, healthy lifestyle habits for people with migraine

Migraine sufferers who experienced reduced stress from one day to the next are at significantly increased risk of migraine onset on the subsequent day, according to a new study conducted by researchers at the Montefiore Headache Center and Albert Einstein College of Medicine at Yeshiva University.

27 Mar 2014

Viewpoints: Be careful what you pray for; health law 'freakouts;' concerns about imported drugs

On Tuesday, the Supreme Court will consider a proposition that will strike many Americans as bizarre: that large, for-profit businesses can refuse on religious grounds to comply with a federal mandate that they include contraception in their employee health plans (3/25).

26 Mar 2014

Biogen Idec's ALPROLIX gets Health Canada approval for hemophilia B

Today Biogen Idec announced that Health Canada has approved ALPROLIX [Coagulation Factor IX (Recombinant), Fc Fusion Protein], for the control and prevention of bleeding episodes and routine prophylaxis in adults, and children aged 12 and older, with hemophilia B.

21 Mar 2014

Elsevier launches Open Access, online-only journal Internet Interventions

Elsevier, a world-leading provider of scientific, technical and medical (STM) information products and services, is pleased to announce the launch of the Open Access, online-only journal Internet Interventions.

20 Mar 2014

Stress undermines our relationships with other people

Stress, this enemy that haunts us every day, could be undermining not only our health but also our relationships with other people, especially if we are men. In fact, stressed women apparently become more "prosocial". These are the main findings of a study carried out with the collaboration of Giorgia Silani, from the International School for Advanced Studies of Trieste.

19 Mar 2014

Medivir announces phase III ATTAIN study of simeprevir inhibitor in treatment of adult patients with HCV

Medivir AB today announced that new phase III data for the once-daily protease inhibitor simeprevir have been presented at the Conference of the Asian Pacific Association for the Study of the Liver (APASL) in Brisbane, Australia.

19 Mar 2014

Headache News and Research

Latest Headache News and Research

Astellas, Medivation submit European Marketing Authorization Application for XTANDI capsules

ER physicians discount early signs of strokes among women, minorities, younger people

Doctors overlook early signs of strokes in people each year

Researchers identify possible way to prevent headaches of climbers

Gilead reports topline results from sofosbuvir Phase 3 trial in Japan for treatment of HCV infection

Frail elderly people are at increased risk of death from outbreaks of viral gastroenteritis

FDA expands age indication of Adacel vaccine for immunization against tetanus, diphtheria, pertussis

Looking forward: How to judge the rollout; challenges to come

UT Southwestern launches telemedicine program to extend stroke care to patients in rural areas

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Biogen Idec's ALPROLIX receives FDA approval for hemophilia B treatment

States work to clarify enrollment rules, untangle technical problems as open enrollment period moves toward its close

First Edition: March 28, 2014

CDC identifies six new cases of people with Heartland virus

Study highlights importance of stress management, healthy lifestyle habits for people with migraine

Viewpoints: Be careful what you pray for; health law 'freakouts;' concerns about imported drugs

Biogen Idec's ALPROLIX gets Health Canada approval for hemophilia B

Elsevier launches Open Access, online-only journal Internet Interventions

Stress undermines our relationships with other people

Medivir announces phase III ATTAIN study of simeprevir inhibitor in treatment of adult patients with HCV

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Headache News and Research

Latest Headache News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in